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Summary
Activation-induced cytidine deaminase (AID) is specif-
ically expressed in the germinal centers of lymphoid
organs, where it initiates targeted hypermutation
of variable regions of immunoglobulin genes in re-
sponse to stimulation by antigen. Ectopic expression
of AID, however, mediates generalized hypermutation
in eukaryotes and prokaryotes. Here, we present evi-
dence that AID is induced outside the germinal center
in response to infection by the Abelson murine leuke-
mia virus. The genotoxic activity of virally induced AID
resulted in checkpoint kinase-1 (chk1) phosphoryla-
tion and ultimately restricted the proliferation of the
infected cell. At the same time, it induced NKG2D
ligand upregulation, which alerts the immune system
to the presence of virally transformed cells. Hence, in
addition to its known function in immunoglobulin di-
versification, AID is active in innate defense against
a transforming retrovirus.
Introduction
The mouse genome encodes three functional cytidine
deaminases with distinct functions in vivo. Apolipopro-
tein B editing catalytic polypeptide-1 (APOBEC1) has
long been recognized as an mRNA-editing enzyme, pro-
ducing a truncated version of Apolipoprotein B that
forms the chylomicron (Anant et al., 2003). Activation-
induced cytidine deaminase (AID) was the second mem-
ber of this family to be characterized. AID is an arbiter of
antigen receptor gene diversity, as it mediates both the
introduction of point mutations into the variable regions
of immunoglobulin (Ig) genes and the deletional recom-
bination between constant regions resulting in Ig isotype
switching (Chaudhuri and Alt, 2004). Murine Apolipo-
protein B editing complex-3 (APOBEC3) is only weakly
homologous to the human APOBEC3 family, members
of which have specific activity against retroviruses like
HIV (Goff, 2003).
Upon infection of a cell with a retrovirus, human APO-
BEC3 deaminases are packaged in the virion and carried
to the next target cell. The encapsidated enzymes de-
aminate the viral minus strand cDNA (Goff, 2003), but
the mechanism by which these deaminases restrict viral
infectivity does not require their catalytic activity (Chiu
et al., 2005; Newman et al., 2005); hence, how these de-
aminases function in antiviral immunity is not fully un-
derstood. Therefore, although human APOBEC3s have
*Correspondence: papavasiliou@rockefeller.edua profoundly deleterious effect on HIV, the molecular de-
tails of how these deaminases function in the context of
antiviral immunity remain unknown. Murine APOBEC3s
also can be incorporated into the virions of simple vi-
ruses (e.g., the murine leukemia virus MLV) and can
deaminate the MLV genome, but their effect on viral
infectivity is weak (Goff, 2003).
Despite their distinct functions in vivo, all three mouse
cytidine deaminases display similar activities in vitro:
they all deaminate single-stranded nucleic acid (DNA
or RNA) (Bransteitter et al., 2003; Chaudhuri et al.,
2003; Dickerson et al., 2003). In addition, all three mole-
cules mutagenize DNA when expressed ectopically in
E. coli (Harris et al., 2002). Although only APOBEC3
deaminases have as their primary function in vivo the
reduction of viral infectivity, there is no a priori reason
why AID or APOBEC1 could not possess similar antiviral
activity.
Abelson murine leukemia virus (Ab-MLV) is a highly
oncogenic transforming retrovirus that causes primary
pre-B cell transformation in vitro and pre-B cell leukemia
in vivo. In both settings, the activity of the single protein
product of the virus, the v-Abl protein tyrosine kinase, is
required. However, despite the presence of this strongly
transforming oncogene, Ab-MLV-induced lymphomas
are usually clonal or oligoclonal, suggesting that other
events in addition to expression of v-Abl are required
for tumor formation and therefore that Ab-MLV-induced
transformation is a multistep process (Rosenberg,
1994).
Here, we show that infection of mouse primary B cells
by Ab-MLV induces AID expression, but in contrast to
APOBEC3s, AID is not packaged in the virion and it
does not deaminate the retroviral genome. Instead, we
show that AID induction within infected cells leads to
checkpoint kinase-1 (chk1) phosphorylation, delays
cell-cycle progression, and restricts the proliferation of
the infected cell. At the same time, the genotoxic action
of AID leads to upregulation of the NKG2D Rae-1 ligand
on the surface of infected cells, which increases their
susceptibility to killing by NK cells. The presence of
Rae-1 on the surface of a developing Abelson tumor en-
hances the survival of the infected animal, further sug-
gesting that AID is central in the ability of the host to limit
the proliferation of infected cells, resulting in their even-
tual elimination from the system.
Results
AID Deficiency Increases the Susceptibility
to Viral Transformation
To test whether AID might play a role in antiviral immu-
nity, we infected bone marrow cells from wild-type
(Balb/cByJ) and Balb/cByJ AID-deficient (Aicda2/2)
mice (Ramiro et al., 2004) with replication-deficient Abel-
son murine leukemia virus (Ab-MLV) in vitro. Even
though bone marrow consists of a complex mixture of
cells, Ab-MLV naturally transforms with highest speci-
ficity a subset of developing B cells (specifically pro-
to-pre-B cells), and the efficiency of transformation
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780Figure 1. Response of Wild-Type and Aicda2/2 Cells to Ab-MLV Infection
(A) AID-deficient B cells produce higher numbers of transformants upon infection with Ab-MLV virus. 23 106 bone marrrow cells were infected
with replication-deficient Ab-MLV and cultured in soft agar. Foci of transformed cells were counted 10 days postinfection. Uninfected primary
cells produced no foci (moi = multiplicity of infection).
(B) Ab-MLV infects wt and Aicda2/2 B cells with equivalent efficiencies. 23 106 bone marrrow cells were infected with replication-deficient Ab-
MLV-GFP (moi 0.1), and the proportions of infected (GFP+) cells in each culture were analyzed by FACS via antibodies to B220+ (a pan-B cell
marker) and the internal green fluorescence produced by infected cells. The numbers in the upper right corner indicate the range of percentages
of GFP+ B cells recovered at the indicated time points in 10 independent experiments.
(C) Wild-type cells transformed by Ab-MLV are restricted in their proliferation compared to AID-deficient counterparts. 23 106 bone marrow cells
were infected with replication-deficient Ab-MLV-GFP (moi 0.1), and the absolute numbers of live infected cells were counted on the days indi-
cated. Error bars indicate standard deviation from the mean (5 experiments).
(D) The number of dead cells was compared in cultures of wt or Aicda2/2 infected cells.
(E) Uninfected, primary B cells of either wild-type or Aicda2/2 genotype were tested for survival in culture in the absence of infection.can be precisely quantified by a semisolid agar assay
and by counting the resulting foci (which are usually
macroscopically visible 9 to 12 days postinfection)
(Rosenberg and Baltimore, 1976). We found that AID-
deficient B cells produce on average three times more
transformed foci compared to wild-type mice of the
same genetic background, and the number of foci is
proportional to the multiplicity of infection (Figure 1A
and Figure S1A in the Supplemental Data available
with this article online).
An increase in susceptibility to transformation could
be a consequence of perturbations in lymphoid sub-
populations in AID-deficient mice, and hence of more
virus-susceptible targets. To determine the numbers of
Ab-MLV targets in AID-deficient and wt bone marrow,
we labeled bone marrow cells with antibodies against
B220 (a general B cell marker) and analyzed the kinetics
of appearance of GFP+ Ab-MLV transformed cells. We
found that 0.5%–0.7% of bone marrow cells were GFPpositive the first day, and all of them were B cells
(Figure 1B, day 1, and Figure S1B). This range was the
same for both strains (10 independent experiments).
Therefore, the subpopulation of B cells infected by Ab-
MLV is equivalent in wt and AID-deficient strains.
However, although infection of Aicda2/2 and wt bone
marrows began with similar numbers of GFP-positive
cells, the transformed cells did not proliferate equally.
Expansion of both sets of cultures was identical
until days 5–6 after infection; however, after day 7,
Aicda2/2 transformed cells proliferated markedly faster
than their wt counterparts (Figure 1C), and this prolifer-
ation differential was also evidenced in the number of
transformed foci at day 10 (Figure 1A) as well as in their
size (with Aicda2/2 foci being on average larger than wt
foci; data not shown). The difference in proliferation
cannot be explained by increased cell death in the
infected wt cultures, because equivalent numbers of
trypan blue-positive dead cells were counted in the
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781Figure 2. Infection with Ab-MLV Induces AID
Expression, and AID Induction Requires that
the Viral Genome Is Reverse Transcribed
(A) Kinetics of AID upregulation in Ab-MLV-
infected (GFP+) cells as analyzed by quantita-
tive real-time PCR and normalized against
uninfected controls that did not express AID
(moi = 0.1). Error bars represent the standard
deviation from the mean (5 independent
experiments).
(B) Kinetics of AID upregulation in cultures of
cells infected with reverse transcriptase mu-
tant (DRT) Ab-MLV. Insert: immunoblot con-
firming equal detection of p30-gag from viral
supernatants of Ab-MLV and Ab-MLV DRT,
after centrifugation on sucrose cushions
(20 mL and 5 mL).wt and Aicda2/2 culture (Figure 1D). Additionally, un-
infected Aicda2/2 and wt cells had identical survival
curves in culture (Figure 1E). Therefore, AID-sufficient
wt cells appear genetically more resistant to viral trans-
formation.
Bone Marrow, Wild-Type Cells Induce AID
Expression upon Viral Infection
AID is thought to be expressed solely in germinal cen-
ters, which are regions of lymphoid organs where SHM
and class switch recombination take place (Muramatsu
et al., 1999). To determine whether AID is also expressed
in primary bone marrow cells in response to viral infec-
tion, we sorted GFP+ B cells after infection, isolated their
mRNA, and analyzed it by quantitative PCR. We found
that AID mRNA was induced 5 days after infection and
that expression continued to increase subsequently
(Figure 2A). We did not observe substantial AID expres-
sion in uninfected bone marrow cells (Figure 2A, day 0;
Muto et al., 2000).
The expression of infection-induced AID was about
10% of AID mRNA at the peak of the class switch recom-
bination reaction (data not shown). When we infected
bone marrow cells with a reverse-transcriptase mutant
of the virus (DRT), it failed to upregulate AID (Figure 2B),
even though the number of viral particles of the RT mu-
tant virus was identical to that of the wt (Figure 2B,
insert). Therefore, we conclude that AID induction in
infected cells requires reverse transcription of the viral
genome.
The increase in AID mRNA after day 5 (Figure 2A) pre-
cedes the increased proliferation of the Aicda2/2 cells at
days 6–7 (Figure 1C). That this proliferative burst is not
observed in wild-type cells suggests that AID may playa role in reducing the proliferative potential of wt trans-
formed cells.
AID normally targets the immunoglobulin locus, but
when expressed in nongerminal center cells, it can initi-
ate mutation of a number of highly transcribed genes
(Martin et al., 2002). To determine whether the AID ex-
pression we observed was physiologically functional,
we cloned and sequenced the JH4 intron of the immuno-
globulin locus from wt and Aicda2/2 transformed cells
10 days postinfection. We found that the JH4 locus
was mutated in 10 out of 34 of the wt clones (16 muta-
tions in 23,800 nts, mutation frequency 0.68 3 1023),
but only one clone was mutated in 38 sequences from
Aicda2/2 cells (1 mutation in 26,600, mutation frequency
0.09 3 1023) (Table 1 and Figure S2). Within the B cell
compartment, Ab-MLV transforms exclusively pre-B
cells, and thus it is unlikely that the JH4 mutations we de-
tected were due to contaminating recirculating B cells.
We also cloned and sequenced the l5 gene, which is
highly expressed in pre-B cells, with similar results
(Table 1 and Figure S2). We conclude that the virally
induced AID expression that we observe results in the
production of enzymatically active protein.
AID Protects Wild-Type Mice from Acute
Death Resulting from Ab-MLV Infection
and Transformation
To determine whether the altered transformation profile
of Aicda2/2 cells in culture reflects a potential cell-au-
tonomous effect on disease progression in the infected
Aicda2/2 animal, we engrafted equivalent numbers of
Ab-MLV-infected bone marrow cells from either wt
Balc/cByJ or congenic Aicda2/2mice into Balc/cByJ re-
cipients. Because infected cells of both genotypes areTable 1. Mutation Frequencies of the JH4 and l5 Loci in Wild-Type or AID
2/2 Cells Infected with Ab-MLV
Clones Mutated Mutation Frequency 3 1023 % dG,dC
Locus Wild-Type AID2/2 Wild-Type AID2/2 Wild-Type AID2/2
JH4 10/34
a 1/38a 0.68 0.09 75 -b
l5 6/24c 0/18c 1.19 0 100 -
Statistical significance was evaluated by the c2 test for the indicated sets of data.
a p < 0.01
b All mutations were from dA,dT.
c p < 0.025
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body isotypes, this experiment uncouples a direct role
of AID in the response to viral infection from an indirect
role in generating neutralizing isotypes.
Sick mice presented with impaired gait, paraplegia,
and in many cases a detectable subcutaneous tumor
mass, all pathologies symptomatic of Ab-MLV-induced
disease (Abelson and Rabstein, 1970). We confirmed
the diagnosis of Abelson disease by performing gross
pathological examination, histochemical staining, and
FACS analysis (not shown). Only mice receiving infected
bone marrow became ill (Figure 3). Mice receiving in-
fected wt bone marrow died beginning 48 days postin-
fection, and 70% were dead after 65 days; 30% re-
mained disease free (Figure 3).
In contrast, in mice receiving infected Aicda2/2 bone
marrow, disease progressed far more rapidly: mice be-
gan dying 24 days after infection, and more than 90%
were dead by 48 days. In other words, almost all mice re-
ceiving infected Aicda2/2 bone marrow died before any
of their wt counterparts did (Figure 3). Indeed, a statisti-
cal comparison of the two survival curves revealed that
the difference between them is highly significant (log-
rank test, p = 4.8 3 1025). A third of the mice trans-
planted with infected Aicda2/2 bone marrow did not
present with classical features of Abelson disease.
Rather, they died suddenly of thoracic hemorrhage
due to a highly aggressive and invasive pre-B cell tumor.
These in vivo data strongly suggest that AID functions
in a cell-autonomous fashion in the host response to in-
fection caused by transforming viruses by restricting the
acute phase of the disease. Importantly, this function of
AID is independent of its role in antibody diversification.
Functional AID in Infected Wild-Type Cells Leads
to NKG2D Ligand Expression and to chk-1
Phosphorylation
Because AID is expressed well after the virus is inte-
grated in the host genome, it is unlikely that it directly
deaminates the viral genome during the early stages of
infection, prior to provirus formation. Indeed, we did
not find any mutations when we amplified and se-
quenced parts of the viral genome at early time points
after infection (the GFP and gag genes; data not shown).
Figure 3. AID Protects Wild-Type Mice from Acute Death after Ab-
MLV Infection
The survival of lethally irradiated Balb/cByJ mice engrafted with Ab-
MLV-infected wild-type (20 recipients; shown in triangles) or Ab-
MLV-infected AID-deficient BM cells (20 recipients; shown in circles)
is presented as a Kaplan-Meyer plot. After engraftment, irradiated
recipients were monitored daily and analyzed shortly after death.Thus, unlike the human APOBEC3 deaminases, mouse
AID does not specifically target the virus, and as a result
all transformed cells are GFP+.
To investigate whether virally induced AID could dam-
age the genome of infected cells, we assayed cell-sur-
face expression of ligands, which have recently been
identified as markers of genotoxic stress (Gasser et al.,
2005). We monitored the expression of the Rae-1 and
H60, which are NKG2D ligands on the surface of Balb/
cByJ and AID-deficient Balb/cByJ B cells at several
time points after infection. The Rae-1 ligand, which is
upregulated in response to DNA damage (Gasser
et al., 2005), appears on the surface of Ab-MLV-infected
Balb/cByJ cells by 6 days after infection (Figure 4A, top,
black trace). In contrast, surface expression of Rae-1
ligands were significantly reduced in Ab-MLV-infected
Aicda2/2 cells (Figure 4A, gray histogram). Furthermore,
expression of the NKG2D ligand H60, which is constitu-
tively present on the surface of Balb/cByJ pre-B cells
(Figure 4A; Malarkannan et al., 1998) but has not been
linked to the DNA damage response, is not further in-
duced in Ab-MLV-infected Balb/cByJ cells (Figure 4A,
bottom, black trace). Therefore, coincident with AID up-
regulation, virus-infected wt cells upregulate the Rae
family of NKG2D ligands whereas congenic Aicda2/2
infected cells do not.
The inability of AID-deficient cells to upregulate Rae1
ligands after infection by Ab-MLV is not due to a general
deficiency in the response of such cells to DNA damage:
both Balb/cByJ and Aicda2/2 cells can upregulate
Rae-1 ligands after exposure to ionizing radiation (Fig-
ure 4B). The magnitude of the NKG2D response to ioniz-
ing radiation is similar to that seen in wt infected cells
(day 7 after infection and beyond, Figure 4A).
Finally, Rae ligand upregulation makes infected Balb/
cByJ cells sensitive to killing by NK cells (Figure 4C). This
finding could explain why Ab-MLV-infected Aicda2/2
cells kill wt mice rapidly (Figure 3): essentially, AID2/2
cells, which do not upregulate Rae ligands (Figure 4A,
top, gray histogram), lack the surface molecule that
marks their wt counterparts for clearance by NK cells.
To further confirm that the observed increase in Rae-1
ligand expression was due to AID activity and not to
other cellular processes initiated by viral infection and
transformation, we examined splenic B cells for Rae-1
expression during class switch recombination. Splenic
B cells can be induced to isotype switch after stimulation
with LPS and IL-4. Although the new isotype is not de-
tectable on the cell surface until about 72 hr postinduc-
tion (Figure 5A), switch recombination is completed at
the molecular level by 48 hr after induction, coincident
with AID expression and DNA break formation (Figure 5C;
Schrader et al., 2005). We found that Rae-1 ligands were
dynamically expressed on the surface of wt B cells be-
tween 48 and 60 hr postinduction. Rae-1 surface expres-
sion was dependent on the presence of AID (Figure 5B)
and was reduced to background amounts by 80 hr after
induction. Thus, Rae-1 ligand expression appears to be
closely linked to the presence of functional AID.
NKG2D ligand upregulation has been linked to activa-
tion of the ataxia telangiectasia mutated (ATM) damage
checkpoint (Gasser et al., 2005), which eventually in-
hibits entry of damaged cells into mitosis by activation
of the effector kinase Chk1. This activation is achieved
A Role for AID in the Host Antiviral Response
783Figure 4. Virally Induced AID Mediates NKG2D Ligand Expression
(A) Expression of the NKG2D ligands Rae1 (top) and H60 (bottom) in wild-type (black traced histogram) and Aicda2/2 (gray shaded histogram)
infected cells as a function of time. The dashed line indicates staining with an isotype control antibody (iso). Note that the same isotype control is
used for Rae as well as H60 staining.
(B) Rae1 expression in wt and Aicda2/2 cells after exposure to ionizing radiation (4 Gy).
(C) Wild-type cells that express Rae ligand as a consequence of the host response to Ab-MLV infection can be eliminated by NK cells. Infected,
GFP+ wt and Aicda2/2 cells were incubated with MACS purified, splenic NK cells at days 5, 6, and 7 postinfection. Infected cells were incubated
for 1 hr 30 min with increasing amounts NK cells and then stained with propidium iodide (which stains live cells rendered permeable by NK cells).
Double positive (GFP+PI+) cells have been successfully attacked by NK cells. The experiment was done in duplicate.when ATM directly phosphorylates chk1 on Ser345
(Zhao and Piwnica-Worms, 2001) and NKG2D ligand ex-
pression closely follows chk1 phosphorylation (Gasser
et al., 2005). To determine whether chk1 phosphoryla-
tion correlated with Rae ligand expression in Ab-MLV-
infected cells, we monitored the amounts of Ser345-
phosphorylated chk1 by immunoprecipitation followed
by immunoblotting. By using an antibody specific to
the phosphorylated form of chk1, we were able to detect
low levels of chk1 phosphorylation in wt infected cells as
early as 6 days after infection (Figure 6). In contrast,
Aicda2/2 infected cells did not accumulate substantial
amounts of phosphorylated chk1 (Figure 6). This finding
could directly explain the delay in proliferation between
wt and Aicda2/2 cells (Figure 1C) after infection. We
conclude that virally induced AID leads to genotoxic
stress in wt cells, which leads to a decrease in the pro-
liferating potential of the infected cell population by
a mechanism that employs chk1 phosphorylation.
Discussion
The targeted deamination of cytidine residues in nucleic
acids has emerged as a central mechanism in the hostcell arsenal against retroviruses (Sheehy et al., 2002).
At the same time, targeted deamination of antibody
genes has been recognized as crucial for the generation
of antibody diversity, specificity, and even memory
(Muramatsu et al., 2000).
AID is the cytidine deaminase that is essential for the
initiation of Ig diversification in the secondary lymphoid
organs and was therefore thought to be expressed only
within germinal centers where somatic hypermutation
and class switch recombination take place. We report
here that infection of primary cells by a transforming
virus, Ab-MLV, induced AID expression in nongerminal
center B cells. In contrast to the APOBEC3s, AID was
not constitutively present in B cells, but was expressed
by the cell after viral infection. AID was not packaged in
the virion (not shown) and did not reduce viral infectivity.
Rather, it restricted the proliferation of cells infected by
the Abelson retrovirus.
Virus-induced AID is catalytically active: we have
shown that it can mutate transcribed genes. Previous
work from a number of laboratories has shown that
ectopically expressed AID can deaminate many tran-
scribed genes in addition to those encoding Ig (Pe-
tersen-Mahrt et al., 2002; Poltoratsky et al., 2004; Sale
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784Figure 5. Rae-1 Is Expressed on the Surface
of Switching B Cells
(A) Time course of surface expression of IgG1
and IgG3 after treatment of wt and Aicda2/2
splenic B cells (Balb/cByJ strain) with LPS
and IL-4.
(B) Time course of Rae-1 receptor surface
expression after treatment of wt and AID2/2
splenic B cells (Balb/cByJ strain) with LPS
and IL-4. iso, isotype control.
(C) Levels of AID protein in wt cells stimulated
with LPS and IL-4 for the indicated times
(whole-cell extract is run on 4%–20% SDS-
PAGE, blotted onto PVDF membranes, and
probed with the indicated antibodies).and Neuberger, 1998; Wang et al., 2004; Yoshikawa
et al., 2002). We therefore hypothesized that virally in-
duced AID would retard the proliferation of primary
transformed cells by causing generalized DNA damage.
Recent work has linked DNA damage in primary cells
to upregulation of ligands of the NKG2D receptor. We
therefore asked whether the activity of virally induced
AID leads to NKG2D ligand upregulation. Indeed, we
found that wild-type cells upregulate the Rae-1 NKG2D
ligand with kinetics that correlate with the kinetics of
AID induction. In contrast, congenic Aicda2/2 primary
transformants do not upregulate Rae-1. A similar corre-
lation between the kinetics of AID expression and Rae-1
ligand upregulation can be seen in B cells stimulated to
undergo class switch recombination in vitro. Our data
Figure 6. Virally Induced AID Mediates chk1 Kinase Phosphory-
lation
Equal amounts of whole-cell extracts from infected wt and Aicda2/2
cells were probed for the presence of chk1 and phospho-chk1 as
indicated.suggest that NKG2D ligand upregulation is not a result
of viral infection or primary transformation but rather
a direct result of AID activity in the transformed cells.
Furthermore, NKG2D ligand upregulation in response
to genotoxic stress is directly dependent on the effector
kinase chk1 that is phosphorylated by the ATM kinase
upon DNA damage (Gasser et al., 2005). We find that
Ab-MLV-infected wt cells but notAicda2/2 cells accumu-
late phospho-chk1 with kinetics similar to those of AID in-
duction and Rae-1 surface expression. Therefore, our
data mechanistically link AID activity to chk1 phosphory-
lation. As ATM has been shown to be the kinase respon-
sible for chk1 phosphorylation, we speculate that AID
activity in infected cells activates the ATM damage-
response pathway, which would explain the reduced
proliferation of Ab-MLV-transformed wild-type cells.
Finally, we have compared the progression of Abelson
disease in wt mice carrying infected bone marrow cells
from either wt or Aicda2/2 congenic animals. We found
that all wt mice carrying AID null tumors died of pre-B
cell lymphomas very early, whereas wt mice carrying
wild-type tumors lived significantly longer. These
in vivo data provide a genetic demonstration that AID
expressed in a tumor of viral etiology is important in
restricting disease.
In this study, we have used the finding that NKG2D
ligands can be upregulated in cells in response to DNA
damage as a tool to probe whether AID expression in re-
sponse to infection can lead to the activation of the DNA
damage response. Our observation that AID activity can
A Role for AID in the Host Antiviral Response
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surface of wt cells as well as the resulting differential
susceptibility to NK cell-mediated clearance in vitro
could partially explain why Ab-MLV-infected Aicda2/2
cells kill wt mice rapidly. However, conclusive proof for
the involvement of NK cells in clearance of wild-type
Ab-MLV-infected cells from the mouse would require
NK cell-depletion experiments for the duration of the
in vivo studies. Clearly, more work needs to be done
both in vivo and in vitro to conclusively address the role
of these receptors in the NK cell-mediated clearance
of virally infected cells.
It is important to note that the limitation of disease
seen in the wild-type cannot be due exclusively to Rae-
1 upregulation and NK cell killing. Indeed, we have
shown that it is the AID-dependent activation of the
DNA damage response that limits cell proliferation
in vitro in a cell-autonomous manner. Therefore, tumor
development in the mouse could be limited indepen-
dently of NK cell killing. It is quite likely that limitation of
disease requires both the AID-mediated proliferation ar-
rest as well as the clearance of infected cells by NK cells.
AID-mediated restriction of proliferation of virally in-
duced tumors may not be limited to Ab-MLV. EBV infec-
tion can induce AID expression early after viral entry (our
preliminary data). Others have shown that HCV infection
of the human Burkitt’s lymphoma line Ramos, which hy-
permutates constitutively in culture (Sale and Neuberger,
1998), raises levels of AID, resulting in genome-wide mu-
tation and a loss of proliferative potential (Machida et al.,
2004). These viruses are quite different from each other in
capsid composition, making it unlikely that they induce
AID expression by binding a common cell-surface recep-
tor. Furthermore, common signaling cascades initiated
by virally induced interferons do not upregulate AID ex-
pression (our preliminary data). It is possible that AID is
induced by some element of the process of transforma-
tion. In that regard, it will be important to determine
whether viruses causing nontransforming yet persistent
infections upregulate the AID response in the host.
We describe a novel role for AID in the host response
to infection with transforming viruses. Unlike the APO-
BEC3 deaminases that target the virus to reduce infec-
tivity, AID restricts infected cell proliferation in vitro
and the acute (hyperproliferative) phase of the disease
in vivo. Hence, the APOBEC3 deaminases and AID
have complementary roles.
Experimental Procedures
Cells and Mice
293T cells were grown in Dulbecco’s modified Eagle’s medium (Invi-
trogen) supplemented with 10% fetal calf serum (FCS) (Sigma).
Bone marrow cells were flushed from the femurs and tibias of 5- to
8-week-old mice and were grown in RPMI 1640 medium (Sigma)
supplemented with 20% heat-inactivated FCS and 50 mM 2-mercap-
toethanol (Sigma).
Balb/cByj mice were obtained from Jackson Laboratories, and
congenic AID-deficient mice were obtained from Dr. M. Nussenz-
weig (Rockefeller University) (Ramiro et al., 2004). All animal work
was approved by the Rockefeller Institutional Animal Care and
Use Committee.
Retroviral Expression Vectors
The pMIG-vAbl-MLV-120 retrovirus expressing v-Abl tyrosine ki-
nase was a gift from Dr. Naomi Rosenberg (Tufts University Schoolof Medicine, Boston, MA). The pCNL construct for the production
of Abelson virus with a mutant reverse transcriptase (YMDD motif)
was a gift from Alice Telesnitsky (University of Michigan) via
S. Goff (Columbia University).
Virus Production and Infections
Replication-deficient Ab-MLV was generated by transfection of
293T cells with pMIG-Ab-MLV retroviral construct and pCL packag-
ing DNA (1:1 ratio) by the PerFectin Transfection Reagent (Gene
Therapy Systems) according to the manufacturer’s protocol. Cells
were cultured for 48 hr, and the supernatant was filtered through
a 45 mm filter and used as viral stock for infection of target cells.
Viral titers (infectious units/ml) were determined by counting the
number of GFP+ cells that arose after infection of 3T3 cells with dif-
ferent dilutions of viral stock (multiplied by the dilution factor). For
Ab-MLV infections, 2 3 106 bone marrow cells were challenged for
2 hr with a multiplicity of infection (moi) of 0.1. For the experiments
with RT mutant virus, titers were determined by Western blots of
viral gag protein (see below).
Agarose Transformation Assay of Bone Marrow Cells
2 3 106 freshly prepared bone marrow cells from BALB/cByJ and
AID-deficient mice were infected with equivalent titers of Ab-MLV
for 4 hr and seeded in 0.3% agar (usb) containing RPMI-20%FCS-
50 mM-b-mercaptoethanol as described previously (Rosenberg
and Baltimore, 1976). Macroscopic colonies of transformed pre-B
cells were counted between 9 and 12 days postinfection (data
shown are for day 10 foci).
Tumorigenicity Assay
Bone marrow cells were isolated from 5- to 6-week-old BALB/cByJ
and AID2/2 congenic mice and were infected for 2 hr with equivalent
titers of replication-deficient Ab-MLV. After infection, the cells were
washed with 13 PBS and injected intravenously into lethally irradi-
ated (800 rads) BALB/cByJ 8- to 10-week-old female mice. Five re-
cipients from each strain were injected with mock-infected bone
marrow cells, and 20 recipients from each strain were injected
with virus-infected bone marrow cells (1 million bone marrow
cells/mouse). Mice were monitored daily and analyzed soon after
death by gross pathology, histology, and FACS.
NK Susceptibility Assay
NK cells were prepared by depletion of splenocytes of all other cell
types via MACS beads (NK isolation kit, Miltenyi Biotech). NK cells
were then incubated with GFP+ infected B cells at the indicated
effector-to-target ratios for 1.5 hr at 37ºC. After incubation, cells
were washed with PBS-5%BSA buffer and directly stained with pro-
pidium iodide (PI), which stains cells rendered permeable by NK
treatment (a more extensive protocol is provided with the NKTest
kit, Orpegen Pharma). Percentages of double positive (GFP+PI+)
intact cells at different effector-target ratios were then plotted.
Flow Cytometry Analysis
For the quantification of GFP+ B cells, bone marrow cultures were
stained with mouse B220 PE-conjugated antibody (BD Pharmigen).
7AAD was used for dead cell exclusion.
NKG2D ligand upregulation was monitored by means of primary
antibodies against Rae1 (pan-Rae, R&D Systems clone 186107, rat
IgG2a), H60 (R&D Systems, clone 205326, rat IgG2a), and isotype
controls (rat IgG2a, R&D Systems) in combination with a PE-labeled
anti-rat IgG (R&D Systems).
Class switch recombination was monitored with antibodies
against IgG1 and IgG3 in conjunction with anti-B220 (BD Pharmin-
gen).
Immunoblots
For detection of viral proteins, viral supernatants were centrifuged
on a sucrose cushion. Virions were collected, resuspended in 13
Laemmli buffer (with 100 mM DTT), boiled for 10 min and then imme-
diately loaded onto a Tris-glycine 4%–20% acrylamide gradient gel
(BioRad). The gel was transferred onto PVDF membrane and incu-
bated with antibodies against gag (Cell Signaling Technologies).
Chk1 expression was assessed by Western blotting infected cell
lysates with antibodies against total chk1(via a chk1 antibody from
Immunity
786Cell Signaling Technologies), phospho-chk1 (Ser345 specific [Cell
Signaling Technologies]), or b-actin.
Quantitative Real-Time PCR
Bone marrow cells from 5- to 8-week-old BALB/cByJ mice were in-
fected with Ab-MLV as described above. The cells were collected at
different days postinfection and stained with mouse B220 PE conju-
gated antibody. Cell sorting was performed on a FACSVantageTM
(Becton Dickenson).
Total RNA was extracted from GFP+B220+ samples by Trizol (Invi-
trogen), according to the manufacturer’s instructions. RNA was
treated with DNase I (Promega) at 1 U/mg. Reverse transcription
was performed by Superscript III reverse transcriptase (Invitrogen)
and random hexamers. Primers for AID amplification were a gift
from B. Reina. Results were normalized to GAPDH.
Sequencing Analysis
DNA was prepared from infected or uninfected bone marrow cells,
and gene fragments were amplified with Pfu DNA polymerase (Stra-
tagene). Amplification products were ligated into the TOPO cloning
vector (Invitrogen), and individual clones were sequenced by the
M13F primer. For the amplification of JH4, the sense primer was
50-gtatccgatgcatagggacaaag and the antisense was 50-cctctccagt
ttcggctgaatcc; for l5 the sense primer was 50-gcccttagaacactggc
cttg and the antisense was 50-gcagtgtagatcaagggcg.
Supplemental Data
The two supplemental figures can be found with this article online at
http://www.immunity.com/cgi/content/full/24/6/779/DC1/.
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